Six Covid-19 vaccines are currently undergoing clinical trials in India – Indian news

Informing that the General Medical Regulator of India has given authorization for the clinical trials of one more candidate vaccine from India, NITI Aayog Member (Health) Dr VK Paul on Tuesday said that six vaccines are currently undergoing clinical trials in the country.

“This week, the Comptroller General of Medicines in India granted authorization for clinical trials for one additional candidate vaccine from India. A Genoa company, with the help of the Department of Biotechnology of the Government of India research agency, has developed a vaccine,” said Dr. Paul speaking at a press conference here.

He said the technology used in this is the same as the Pfizer vaccine.

“Unlike a Pfizer vaccine or some other vaccine, this vaccine – if it does occur – will remain available in normal cold chain conditions, in a normal refrigerator. Currently six vaccines are undergoing clinical trials in this nation,” Dr. Paul said.

NITI member Aayog also expressed concern about the spread of Covid-19 amid ongoing protests by farmers at the borders of the national capital. “We have to be careful, messages have been sent to them (farmers) by the government. Democratic process has to continue but we also have to follow Covid-19 guidelines,” he said.

Praising the States and Union Territories that have recently dropped the growth of Covid-19 cases, Dr Paul said they are happy to note that Delhi has made progress.

“We congratulate the Government of Delhi as well as other governments that have contributed so well to such significant control in recent times. There are states where we still have concerns. We call on the government and citizens of Utarakhand, Nagaland and Himachal Pradesh to let’s try to control the situation, ”Paul said.

Ministry of Health and Family Welfare Rajesh Bhushan, speaking at the press conference, said the number of cases per million population in India continues to be among the lowest in the world.

“29,000 cold chain points, 240 inlet refrigerators, 70 inlets, 45,000 ice refrigerators, 41,000 deep freezers and 300 solar refrigerators will be used. All of this equipment has already reached state governments,” Bhushan said.

He said the number of COVID-19 cases in India is 7,178 per million inhabitants, while the global average for the same is 9,000. He also expressed concern about the adverse effects of immunization and suggested to the States and Union Territories to prepare for the same.

“Bad events after immunization are a critical issue. When we undertake a universal immunization program, done for decades, then some harm is seen in children and pregnant women after vaccination,” Bhushan said.

“So, we can’t deny possibilities of an adverse event when a vaccine against Covid starts. In countries where immunization has already begun, especially in the UK, adverse events have occurred on the first day. So, it is essential that states and UTs also prepare for that, ”he added.

This is happening as the total number of Covid-19 cases in India has reached 99.06.165 with 22,065 new cases and 254 new deaths, the Ministry of Health and Family Welfare said earlier today. To date, a total of 1,43,709 people have died from the virus.